Science Explorer Back to mapMap
Discussion
Researcher · Klinikum Ludwigsburg · Germany

Stefan Angermeier

Stefan Angermeier publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Surgery, on topics such as Gastric Cancer Management and Outcomes, Esophageal Cancer Research and Treatment and Gastrointestinal Tumor Research and Treatment.

OpenAlex
World rank
#1,929,641
of 7,710,434 ranked researchers
Rank in Germany
#95,280
of 364,343
Works
43
Citations
611
Citations per work
14.2
h-index
11
i10-index 12Top 46% in Pulmonary and Respiratory Medicine
Stefan Angermeier

What does Stefan Angermeier research?

Stefan Angermeier's work is mostly in Medicine (83%), Biochemistry, Genetics and Molecular Biology (6%).

Health Sciences: 36 works · 83.4% of their workMedicine: 36 works · 83.4% of their workPulmonary and Respiratory Medicine: 12 works · 28.6% of their workOncology: 12 works · 27.0% of their workSurgery: 7 works · 15.9% of their workGastroenterology: 5 works · 11.9% of their workEverything else: 4 works · 10.2% of their workLife Sciences: 3 works · 6.4% of their workBiochemistry, Genetics and Molecular Biology: 3 works · 6.4% of their workCancer Research: 1 works · 3.2% of their workMolecular Biology: 1 works · 3.2% of their workTHEIR WORKStefan Angermeier43works
Life Sciences6%Health Sciences83%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine3683.4%
  2. Everything else410.2%
    1. Biochemistry, Genetics and Molecular Biology36.4%
  1. 1Pulmonary and Respiratory Medicine29% of their works
  2. 2Oncology27% of their works
  3. 3Surgery16% of their works
  4. 4Gastroenterology12% of their works
  5. 5Cancer Research3% of their works
  6. 6Molecular Biology3% of their works

Research topics

Which keywords describe Stefan Angermeier's research?

The keywords of their largest research topics: Chemotherapy, Endoscopic Resection, Gastric Cancer, Molecular Characterization, Neoadjuvant Therapy, Esophageal Carcinoma, Preoperative Chemoradiotherapy and Tumor Microenvironment.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Chemotherapy403 topics
  2. Endoscopic Resection392 topics
  3. Gastric Cancer231 topic
  4. Molecular Characterization231 topic
  5. Neoadjuvant Therapy202 topics
  6. Esophageal Carcinoma161 topic
  7. Preoperative Chemoradiotherapy161 topic
  8. Tumor Microenvironment162 topics
  9. Imatinib Mesylate151 topic
  10. Sunitinib151 topic
  11. Cetuximab131 topic
  12. KRAS Mutations131 topic
  13. Immune Checkpoint Blockade121 topic
  14. PD-1 and PD-L1121 topic
  15. Targeted Therapy122 topics
  16. ALK Inhibitors81 topic
  17. EGFR Mutations81 topic
  18. Cancer Genomics41 topic
  19. Mutational Signatures41 topic
  20. Pancreatic Cancer41 topic
  21. Surgical Complications41 topic

Where does Stefan Angermeier work?

Stefan Angermeier's main affiliation in the publication record is Klinikum Ludwigsburg, Germany.

How many publications and citations does Stefan Angermeier have?

OpenAlex counts 43 works and 611 citations for Stefan Angermeier, an h-index of 11, ranking #1,929,641 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Stefan Angermeier. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.